Massachusetts Financial Services
AVNS

Massachusetts Financial Services’s Avanos Medical AVNS Stock Holding History

Massachusetts Financial Services’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-68,329
Closed -$1.75M – 839
2023
Q2 		$1.75M Sell
68,329
-1,609
-2% -$42.4K ﹤0.01% 721
2023
Q1 		$2.08M Sell
69,938
-1,979
-3% -$57.5K ﹤0.01% 711
2022
Q4 		$1.95M Buy
71,917
+1,521
+2% +$37.2K ﹤0.01% 731
2022
Q3 		$1.53M Buy
70,396
+9,035
+15% +$236K ﹤0.01% 751
2022
Q2 		$1.68M Buy
61,361
+309
+0.5% +$8.88K ﹤0.01% 742
2022
Q1 		$2.04M Buy
61,052
+626
+1% +$20.2K ﹤0.01% 750
2021
Q4 		$2.1M Sell
60,426
-10,805
-15% -$349K ﹤0.01% 774
2021
Q3 		$2.22M Buy
71,231
+19,758
+38% +$670K ﹤0.01% 773
2021
Q2 		$1.87M Buy
51,473
+441
+0.9% +$18.2K ﹤0.01% 787
2021
Q1 		$2.23M Sell
51,032
-6,049
-11% -$284K ﹤0.01% 758
2020
Q4 		$2.62M Sell
57,081
-579
-1% -$24.1K ﹤0.01% 708
2020
Q3 		$1.92M Sell
57,660
-2,257
-4% -$72.1K ﹤0.01% 721
2020
Q2 		$1.76M Sell
59,917
-1,535
-2% -$44.4K ﹤0.01% 697
2020
Q1 		$1.66M Buy
61,452
+9,726
+19% +$290K ﹤0.01% 699
2019
Q4 		$1.74M Sell
51,726
-12,940
-20% -$469K ﹤0.01% 726
2019
Q3 		$2.42M Buy
64,666
+7,213
+13% +$275K ﹤0.01% 705
2019
Q2 		$2.5M Buy
57,453
+8,005
+16% +$342K ﹤0.01% 708
2019
Q1 		$2.11M Buy
49,448
+1,829
+4% +$81.9K ﹤0.01% 712
2018
Q4 		$2.13M Buy
47,619
+3,706
+8% +$194K ﹤0.01% 702
2018
Q3 		$3.01M Sell
43,913
-101
-0.2% -$6.5K ﹤0.01% 694
2018
Q2 		$2.52M Buy
44,014
+2,670
+6% +$141K ﹤0.01% 702
2018
Q1 		$1.91M Buy
41,344
+639
+2% +$30.3K ﹤0.01% 705
2017
Q4 		$1.88M Buy
40,705
+5,711
+16% +$262K ﹤0.01% 709
2017
Q3 		$1.58M Buy
+34,994
New +$1.49M ﹤0.01% 713
2015
Q4 		– Sell
-17,227
Closed -$490K – 849
2015
Q3 		$490K Sell
17,227
-276
-2% -$9.63K ﹤0.01% 821
2015
Q2 		$709K Sell
17,503
-313
-2% -$14K ﹤0.01% 798
2015
Q1 		$877K Buy
+17,816
New +$825K ﹤0.01% 790

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services's AVNS Position: Q3 2023 in Review

Massachusetts Financial Services sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 68,329 shares — an estimated $1.75M sold.

Massachusetts Financial Services first reported a position in AVNS in Q1 2015 and held it in 27 quarters. The position peaked at $3.01M in Q3 2018. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Massachusetts Financial Services reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 68,329 Avanos Medical shares in Q3 2023, an estimated $1.75M.
  • Massachusetts Financial Services first reported a position in Avanos Medical in Q1 2015 and held it in 27 quarters.
  • Massachusetts Financial Services's Avanos Medical position peaked at $3.01M in Q3 2018.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.